Randomized phase II trial of urethral sparing intensity modulated radiation therapy in low-risk prostate cancer: implications for focal therapy
2012 · Radiation Oncology · 57 citations
https://doi.org/10.1186/1748-717x-7-82
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
58
Papers
1.1K
Citations
18
h-index
27
i10-index
Jeffrey M. Vainshtein is an academic researcher from Western University of Health Sciences. The author has contributed to research in topics: Head and Neck Cancer Studies & Head and Neck Surgical Oncology & Management of metastatic bone disease. The author has an h-index of 18, co-authored 50 publications.
https://doi.org/10.1186/1748-717x-7-82
https://doi.org/10.7759/cureus.93601
Click to start Chat